DNM1L and malignant colon neoplasm: Several studies have shown that the abnormal expression of Drp1 enhances glutaminolysis, aerobic glycolysis, fatty acid metabolism and mitochondrial fission, contributing to the progression of neck cancer, anaplastic thyroid cancer, and colon cancer [39–42].